Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fluidigm Corp (NASDAQ:FLDM)

19.74
Delayed Data
As of Jul 30
 -0.85 / -4.13%
Today’s Change
19.70
Today|||52-Week Range
46.38
-41.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$594.3M

Company Description

Fluidigm Corp. develops, manufactures and markets microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Contact Information

Fluidigm Corp.
7000 Shoreline Court
South San Francisco California 94080
P:(650) 266-6000
Investor Relations:
(650) 266-6081

Employees

Shareholders

Mutual fund holders72.14%
Other institutional37.55%
Individual stakeholders2.92%

Top Executives

Gajus Vincent WorthingtonPresident, Chief Executive Officer & Director
Fredric T. WalderChief Operating Officer
Vikram JogChief Financial Officer
Robert C. JonesExecutive Vice President-Research & Development
Mai Chan YowExecutive Vice President-Worldwide Manufacturing